当前位置: 首页 > 期刊 > 《青岛大学医学院学报》 > 20195
编号:13531387
量化治疗与常规治疗对抑郁症病人疗效及安全性比较(4)
http://www.100md.com 2019年10月1日 《青岛大学学报(医学版)》 20195
     [16]ADLI M, BERGHFER A, LINDEN M, et al. Effectiveness and feasibility of a standardized stepwise drug treatment regimen algorithm for inpatients with depressive disorders: results of a 2-year observational algorithm study[J]. Journal of Clinical Psychiatry, 2002,63(9):782-790.

    [17]ADLI M, RUSH A J, MLLER H J, et al. Algorithms for optimizing the treatment of depression:making the right decision at the right time[J]. Pharmacopsychiatry, 2003,36(S3):222-229.

    [18]BRIDGE J A, IYENGAR S, SALARY C B, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment-a meta-analysis of randomized controlled trials[J]. JAMA, 2007,297(15):1683-1696.

    [19]SIMON G E. Long-term prognosis of depression in primary care[J]. Bulletin of the World Health Organization, 2000,78(4):439-445.

    [20]TRIVEDI M H, RUSH A J, WISNIEWSKI S R, et al. Eva-luation of outcomes with citalopram for depression using mea-surement-based care in STAR*D:implications for clinical practice[J]. The American Journal of Psychiatry, 2006,163(1):28-40.

    [21]HOWLAND R H, THASE M E. What to do with SSRI nonresponders[J]? Journal of Psychiatric Practice, 1999,5(4):216-223.

    [22]BAUER M, PFENNIG A, LINDEN M, et al. Efficacy of an algorithm-guided treatment compared with treatment as usual a randomized,controlled study of inpatients with depression[J]. Journal of Clinical Psychopharmacology, 2009,29(4):327-333.

    (本文編辑 马伟平), 百拇医药(黄飞 姜祥智 徐勇)
上一页1 2 3 4